The phrase “cancer vaccine” has spent decades collecting failed attempts, promising early trials that quietly disappeared once tested at scale. On August 19, that streak broke. Merck and Moderna announced that their Phase 3 INTerpath-001 trial had succeeded, marking the…
Doctiplus - We are allways here!

